Immunosenescence: Molecular Mechanisms, Diseases, And Therapeutic Innovations

Aging Theory
Aging Pathway
Therapeutic
As individuals age, their immune system naturally deteriorates, a process called immunosenescence, which involves molecular changes in immune cells, contributes to various diseases, and is a target for new therapies.
Author

Gemini

Published

December 30, 2025

Ever wonder why older adults seem to catch colds more easily or why vaccines might not work as well for them? It’s largely due to a natural process called immunosenescence, which is essentially the aging of our immune system. As we get older, our immune cells undergo significant changes, becoming less effective at fighting off invaders like viruses and bacteria. This decline isn’t just about fewer immune cells; it’s also about how these cells function. For instance, some cells become “senescent,” meaning they stop dividing but remain active, releasing a cocktail of harmful substances called the senescence-associated secretory phenotype (SASP). These SASP factors contribute to chronic, low-grade inflammation throughout the body, a state often referred to as “inflammaging.” This age-related weakening of our immune defenses has serious consequences. It makes older individuals more susceptible to infections, reduces the effectiveness of vaccinations, and increases their risk for various age-related diseases, including certain cancers and autoimmune conditions. The good news is that scientists are actively exploring ways to counteract this process. Emerging treatments, often called “senotherapies,” aim to either eliminate these problematic senescent cells or block the harmful substances they release. These innovative approaches hold promise for boosting immune function in older adults, potentially leading to healthier aging and better protection against disease.


Source: link to paper